6533b827fe1ef96bd1286831

RESEARCH PRODUCT

Curative therapies for hepatocellular carcinoma: an update and perspectives.

Roberto EggenhöffnerValeria MismasGiampaolo BresciMaurizio RainieriE. TuminoAntonio RomanoMichela AntonucciLuca GiacomelliRodolfo SaccoGiuseppe CabibboAmbra Corti

subject

RFASurgical resectionAblation TechniquesPathologymedicine.medical_specialtyPercutaneousCarcinoma HepatocellularAblative therapymedicine.medical_treatmentLiver transplantationResection03 medical and health sciences0302 clinical medicinemedicineHepatectomyHumansPharmacology (medical)resectionHCCAblative therapy; early stage; HCC; liver transplant; PEI; resection; RFA; Ablation Techniques; Carcinoma Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Oncology; Pharmacology (medical)business.industryCarcinomaLiver NeoplasmsHepatocellularearly stagemedicine.diseasedigestive system diseasesPEISurgeryLiver Transplantationliver transplantOncology030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyLiver cancerbusiness

description

Curative treatments, including liver transplantation, surgical resection and percutaneous treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or BCLC-A hepatocellular carcinoma (HCC). This review provides an overview of some issues of clinical importance concerning curative treatments in HCC.

10.1586/14737140.2016.1123625https://pubmed.ncbi.nlm.nih.gov/26588992